Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Nov 14, 2019

BUY
$65.7 - $83.98 $3.26 Million - $4.17 Million
49,600 New
49,600 $3.61 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Berkley W R Corp Portfolio

Follow Berkley W R Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkley W R Corp, based on Form 13F filings with the SEC.

News

Stay updated on Berkley W R Corp with notifications on news.